Cholangiocarcinoma(CCA) is a malignant tumour that arises from biliary epithelium at any portion of the biliary tree.CCA is currently classified as intra-hepatic or extra-hepatic CCA(EH-CCA).Recent evidences suggest t...Cholangiocarcinoma(CCA) is a malignant tumour that arises from biliary epithelium at any portion of the biliary tree.CCA is currently classified as intra-hepatic or extra-hepatic CCA(EH-CCA).Recent evidences suggest that intra-hepatic CCA(IH-CCA) and EH-CCA are biologically different cancers,giving further support to a number of recent epidemiological studies showing large differences in terms of incidence,mortality and risk factors.The purpose of this manuscript is to review recent literature dealing with the descriptive epidemiology and risk factors of CCA with a special effort to compare IH-with EH-CCA.展开更多
Cholangiocarcinoma(CCA) is a devastating cancer arising from the neoplastic transformation of the biliary epithelium.It is characterized by a progressive increase in incidence and prevalence.The only curative therapy ...Cholangiocarcinoma(CCA) is a devastating cancer arising from the neoplastic transformation of the biliary epithelium.It is characterized by a progressive increase in incidence and prevalence.The only curative therapy is radical surgery or liver transplantation but,unfortunately,the majority of patients present with advanced stage disease,which is not amenable to surgical therapies.Recently,proposed serum and bile biomarkers could help in the screening and surveillance of categories at risk and in diagnosing CCA at an early stage.The molecular mechanisms triggering neoplastic transformation and growth of biliary epithelium are still undef ined,but signif icant progress has been achieved in the last few years.This review deals with the most recent advances on epidemiology,biology,and clinical management of CCA.展开更多
文摘Cholangiocarcinoma(CCA) is a malignant tumour that arises from biliary epithelium at any portion of the biliary tree.CCA is currently classified as intra-hepatic or extra-hepatic CCA(EH-CCA).Recent evidences suggest that intra-hepatic CCA(IH-CCA) and EH-CCA are biologically different cancers,giving further support to a number of recent epidemiological studies showing large differences in terms of incidence,mortality and risk factors.The purpose of this manuscript is to review recent literature dealing with the descriptive epidemiology and risk factors of CCA with a special effort to compare IH-with EH-CCA.
文摘Cholangiocarcinoma(CCA) is a devastating cancer arising from the neoplastic transformation of the biliary epithelium.It is characterized by a progressive increase in incidence and prevalence.The only curative therapy is radical surgery or liver transplantation but,unfortunately,the majority of patients present with advanced stage disease,which is not amenable to surgical therapies.Recently,proposed serum and bile biomarkers could help in the screening and surveillance of categories at risk and in diagnosing CCA at an early stage.The molecular mechanisms triggering neoplastic transformation and growth of biliary epithelium are still undef ined,but signif icant progress has been achieved in the last few years.This review deals with the most recent advances on epidemiology,biology,and clinical management of CCA.
